Physician profile
Joanne MD Chan
NPI 1467426916
$16,665.37
in general payments reported to CMS, 2019-2025
62 companies · $2,778 in 2025
The $2,778 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $1,879 · 2021: $2,321 · 2022: $2,525 · 2023: $2,516 · 2024: $2,472 · 2025: $2,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,661 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,661.45 |
| Education | $105.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,392.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,728.35 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $1,513.98 | 2019-2025 | |
| Abbvie INC. | $1,352.25 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,008.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $941.00 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $692.91 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $600.76 | 2019-2025 | Jardiance, Stiolto Respimat |
| Amarin Pharma, INC. | $575.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $478.56 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $415.99 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $322.90 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $317.85 | 2021-2025 | |
| Mannkind Corporation | $283.23 | 2019-2025 | |
| Amgen INC. | $259.74 | 2019-2023 | Otezla, Repatha |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $221.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.70 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $191.53 | 2019-2025 | Trintellix |
| Sanofi-Aventis U.S. LLC | $189.04 | 2019-2021 | |
| Axsome Therapeutics, INC. | $179.29 | 2023-2025 | Auvelity, Sunosi |
| Allergan, INC. | $173.87 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $152.45 | 2019-2025 | Eliquis, Camzyos |
| Biohaven Pharmaceuticals, INC. | $143.98 | 2020-2021 | |
| Daiichi Sankyo INC. | $143.05 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $142.99 | 2023-2025 | Rexulti |
| Dexcom, INC. | $131.03 | 2021-2025 | Dexcom G6 Transmitter |
| Abiomed | $124.96 | 2022 | |
| Phathom Pharmaceuticals, INC. | $124.94 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $123.37 | 2024-2025 | Zenpep |
| Teva Pharmaceuticals USA, INC. | $122.22 | 2024-2025 | Austedo Xr, Austedo Xr |
| Biogen, INC. | $112.43 | 2020-2022 | |
| Abbott Laboratories | $111.43 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Lundbeck LLC | $92.44 | 2021-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $85.10 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $80.39 | 2023-2025 | Gemtesa |
| Almatica Pharma LLC | $78.66 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $77.71 | 2022 | |
| Alexion Pharmaceuticals, INC. | $65.02 | 2021-2023 | Ultomiris |
| Idorsia Pharmaceuticals US INC | $60.01 | 2022-2024 | Quviviq |
| Prescient Lab Services, LLC | $58.44 | 2025 | Avertd Biofilmchip Microarray Magazine, Avertd Amplification Mix, Avertd Intellipac Reagent Module |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.81 | 2024-2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $51.25 | 2023-2024 | Gvoke Hypopen |
| Sunovion Pharmaceuticals INC. | $49.95 | 2019 | |
| Acadia Pharmaceuticals INC | $49.25 | 2020-2021 | |
| Tactile Systems Technology INC | $47.25 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Nestle Healthcare Nutrition INC. | $42.60 | 2021 | |
| Eisai INC. | $36.89 | 2020 | |
| Currax Pharmaceuticals LLC | $27.26 | 2022 | |
| Antares Pharma, INC. | $26.92 | 2021-2022 | |
| Corcept Therapeutics | $26.26 | 2019 | |
| Ibsa Pharma INC. | $18.98 | 2020 | |
| Mylan Specialty L.P. | $17.82 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.31 | 2025 | |
| Merz Pharmaceuticals, LLC | $17.10 | 2025 | Ampyra, Inbrija |
| Avanir Pharmaceuticals, INC. | $15.51 | 2021 | |
| Seqirus USA INC | $15.32 | 2025 | Fluad, Flucelvax |
| Athena Bioscience, LLC | $15.31 | 2023 | Qdolo |
| C. R. Bard, INC. & Subsidiaries | $13.23 | 2022 | |
| Opko Pharmaceuticals, LLC | $11.66 | 2021 | |
| Scilex Pharmaceuticals INC. | $11.27 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.00 | 2019 | |
| Bardy Diagnostics, INC. | $9.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.